The new STIs on the block are some tricky bacteria. Believe it or not, most providers have never heard of these sexually transmitted infections (STI).

To give you a little history, mycoplasma has been around since the 1980’s, however,  it wasn’t until 2015 when the CDC identified it as an emerging STI. A 2015 study done with 16-44 y/o British males and females showed a link between Mycoplasma genitalium (MG) and sexual transmission. It was concluded that for both men and women,  MG was strongly associated with an increased number of total and new partners and unsafe sex.  Another study in 2007 showed the MG prevalence increases 10% with each additional sexual partner.

Mycoplasma and ureaplasma are two similar types of bacteria. There are over 100 strains of mycoplasma, 2 of them are known to be sexually transmitted: MG, Mycoplasma hominis. The others are related to other disease processes like pneumonia. There are 8 ureaplasma and 2 of these are known to be sexually transmitted; Ureaplasma urealyticum and Ureaplasma parvum.  You might notice some similarities and differences between all of them. One of the differences I ran into is that Ureaplasma and M. hominis can be part of the body’s normal bacterial population; unlike MG. They can live in balance without causing  a problem in most cases. When the balance is off, that leads to an infection. This is similar to bacterial vaginosis in that gardnerella is the primary bacteria that is normally found in vaginal flora, but when the balance is off, you have bacterial vaginosis.

Mycoplasma and ureaplasma are considered non chlamydial, non-gonococcal infections.  For the most part, the research has primarily been done on MG. In the US, MG is the third most common STD among young people. It is estimated about 2-4% of the population has the infection, and about 1% of women have MG. This actually makes it more prevalent than gonorrhea, but less common than chlamydia. HOWEVER, IT IS NOT PART OF A STANDARD STI PANEL.

Scientists are not totally sure about how the mycoplasma and ureaplasma  are transmitted between individuals. It does appear to be spread via genital to genital contact and ejaculation does not have to occur to spread, just like with many other STIs. MG is a slow growing bacterium so scientists are also not sure about the average length of time it takes for the bacteria to cause an infection. This also makes it difficult to test for and requires very special testing.  To get tested for mycoplasma and ureaplasma you will need to see your provider. They will likely obtain a vaginal swab or urine specimen. Currently there are no CDC guidelines for screening for these. Studies show that M. hominis has been isolated from cervicovaginal specimens in 21-53% of women who are asymptomatic and sexually active, whereas ureaplasma has been isolated in  40-80& of women who are asymptomatic and sexually active.

Some individuals will have symptoms. Urethritis may be present which in men includes urethral discharge, irritation, or pain with urination; in women can be vaginal discharge, urethral irritation, and pain with urination. Studies show that 20-35% of non-chlamydial, non-gonococcal, urethritis infections are caused by MG.  Epididymitis or inflammation of the epididymis might be seen which could present with unilateral warmth, tenderness and swelling within the scrotum. In men you might also see balanitis or inflammation of the glans penis, or posthitis, inflammation of the foreskin. In women you might see cervicitis or inflammation of the cervix resulting in vaginal discharge, pelvic pain, pain with intercourse or even bleeding with intercourse or bleeding between periods. MG is detected in about 10-30% of women with cervicitis. With M. hominis, there are articles that show that BV can be a symptom as well. Pelvic inflammatory disease (PID) can also happen with these bacteria. Classic findings of PID include fever, pelvic pain, and  uterine, cervical or ovary tenderness on pelvic exam.

Mycoplasma and ureaplasma can be treated with antibiotics. I recommend  retesting about 3-4 weeks after treatment to ensure the bacteria is gone. Especially, because of the antibiotic resistance that is seen with these infections. Just like with other STI, you will want to make sure partners are  tested and treated as well.

If untreated, mycoplasma and ureaplasma can lead to PID, arthritis, infertility and ectopic pregnancy, chronic pelvic pain. This is similar to other STIs. There is also studies that show that MG can increase risk of contracting HIV.

To prevent mycoplasma and ureaplasma, abstaining or long term mutually monogamous relationship can limit exposure and risk. I initially learned that because this bacterium is so small it can get through the condom, however, a 2017 study did show that condoms also provide protection against these STIs. So, this is good news.

In summary, typically mycoplasma and ureaplasma are asymptomatic. They are not routinely screened for. Next time you are having STI testing ask your provider to screen for both mycoplasma and ureaplasma. If you provider is unable to, I would encourage looking online for some of the online testing sites that will screen for both of these. And there you have it, the new STIs on the block.

Additional sources: